Free Press Release - Aug 02, 2010

MARCK BIOSCIENCES RECORDS A GLOBAL FIRST
Marck Biosciences first to develop Paracetamol IV in plastic pack

• Begins exports to International markets
• To launch in India in December 2010
• F & D team worked for 3 years

Ahmedabad, August 2, 2010: Marck Biosciences Ltd., India’s leading manufacturer and marketer of sterile dosages and Blow-Fill-Seal (BFS) specialist, today scripted a new chapter for the global healthcare industry with the launch of world’s first ever Paracetamol IV in plastic pack manufactured using BFS technology.

Marck has already received the necessary approvals for its Paracetamol IV and is manufactured at Marck’s world class manufacturing facility at Kheda in Gujarat.
Due to the challenge of developing a formulation that is stable in plastic, Paracetamol I.V. has not been so far available in plastic pack using BFS, the latest sterile technology. Marck’s formulation and development team has been working on preparing and studying different formulations of Paracetamol I.V. for the past 3 years to come up with Paracetamol I.V. first time in plastic pack in the world.

“Marck’s passion is bringing difficult to make dosages to life through innovative solutions. The first Paracetamol IV in plastic reflects our commitment to leverage our expertise and develop a portfolio of sterile dosage pharma products to increase the choices available for the healthcare industry. Paracetamol IV in plastic will have lower freight costs and breakages and help in more competitive pricing in comparison to glass bottles,” says Mr Bhavesh Patel, MD, Marck Biosciences.
Marck has begun exporting Paracetamol IV to West Africa markets. The company is in the process of registering the innovative product in other markets. Marck will shortly be launching Paracetamol IV in India.

Paracetamol IV is a ready to infuse dosage form of Paracetamol (in 10 mg/ml solution) and is indicated for the short-term treatment of moderate pain, especially following surgery and for the short-term treatment of fever urgently when other routes of administration are not possible. Paracetamol IV is especially advantageous in non-sterile environments and aids greatly in safe delivery of the drug.

Marck Biosciences is India’s most versatile sterile dosages pharmaceutical company in Blow Fill Seal Space founded on the vision of “Innovating to bring Difficult-to-Make Dosages to Life”. Marck manufactures and markets the widest range of sterile dosages spanning fluid therapy, ophthalmics, respiratory, irrigation solutions and anti-infectives across India.

Besides marketing its own brand, Marck contract manufactures sterile dosage pharma products for top pharma companies in India.

Marck commenced operations in 1998 and today employs over 825 people. The manufacturing facility of Marck Biosciences, located in Kheda (Gujarat) and spread over an area of 25 acres, is benchmarked against global quality standards. The facility is certified by numerous international regulatory authorities including ANVISA (Brazil) & NPCB (Malaysia) – a PIC member country. The plant, equipment and systems have been designed to meet Current Good Manufacturing Practices (cGMP) & Quality Management System as laid down by many International Regulatory Authorities like MCC (South Africa), WHO (Geneva), MHRA (UK) & TGA (Australia). The Plant Quality Management System has been certified for ISO 9001 – 2000 & ISO 13485.